drug resistance

254 проекта

FP6Реинтеграция2006–2006Франция

BOPA · Characterisation and engineering of the biosynthetic pathways of two model pyrrole amide antibiotics, congocidine and distamycin

FP6Реинтеграция2005–2007Унгария

SZAKONYI · Structural and functional studies of different bacterial multi-drug resistance proteins of DMT and MOP super-families

FP6Индивидуална стипендия2005–2007Обединеното кралство

CSOBMTS · Crystallographic studies of bacterial membrane transport systems

FP6Реинтеграция2005–2005Испания

NEW ABCS IN LEISHMAN · Functional and biochemical characterisation of novel ABC transporters of biomedical interest in the protozoan parasite Leishmania

FP6Индивидуална стипендия2005–2007Обединеното кралство

NOTB · Novel Therapeutic Agents for the Treatment of Tuberculosis

FP6Реинтеграция2004–2005Германия

PML NUCLEAR BODIES · Function and regulation of promyelocytic leukemia (PML) nuclear bodies (NB) and their role in innate immunity and antiviral resistance

FP6Обмен на изследователи2004–2008Белгия

LINKING A-D-M-E · How does cross-talk between drug transporters and drug metabolism affect drug disposition

2 партньори · 2 държави

FP6Обмен на изследователи2004–2008Франция

MET-CANCER THERAPY · Animal models and drug design for therapy of cancers induced by the oncogene, met

FP5Индивидуална стипендия2002–2004Обединеното кралство

Cytochromes p450 as drug targets against mycobacterium tuberculosis and mycobacterium leprae.

FP5Обучителен център2000–2004Германия

Gene expression profiling analysis of multidrug resistance in human tumors

FP5Индивидуална стипендия2000–2002Италия

Genetic alterations associated with drug resistance in human osteosarcoma cells

FP4Индивидуална стипендия1998–1999Нидерландия

Intracellular lipid transport and translocation to the cell surface

2 партньори · 2 държави

FP4Индивидуална стипендия1997–2000Обединеното кралство

Elucidation and manipulation of the aminoglycoside antibiotic butirosin

2 партньори · 2 държави

FP6РеинтеграцияКипър

BEACON · Novel molecular beacon technologies for the study of hiv-1 and other infectious agents